CORCEPT THERAPEUTICS INC's ticker is CORT and the CUSIP is 218352102. A total of 58 filers reported holding CORCEPT THERAPEUTICS INC in Q3 2013. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $1,774,000 | -18.0% | 146,637 | -4.2% | 0.05% | -5.8% |
| Q3 2019 | $2,164,000 | +30.0% | 153,081 | +8.0% | 0.05% | +44.4% |
| Q1 2019 | $1,665,000 | +109.4% | 141,792 | +138.4% | 0.04% | +71.4% |
| Q4 2018 | $795,000 | -85.6% | 59,471 | -79.4% | 0.02% | -80.2% |
| Q3 2017 | $5,515,000 | +15.2% | 289,058 | -28.7% | 0.11% | +11.6% |
| Q2 2017 | $4,787,000 | +84.0% | 405,694 | +71.0% | 0.10% | +50.8% |
| Q1 2017 | $2,601,000 | -2.5% | 237,317 | -35.4% | 0.06% | -33.7% |
| Q4 2016 | $2,669,000 | +66.6% | 367,634 | +49.2% | 0.10% | +93.9% |
| Q3 2016 | $1,602,000 | +201.7% | 246,467 | +153.3% | 0.05% | +188.2% |
| Q2 2016 | $531,000 | +8.1% | 97,291 | -7.2% | 0.02% | +21.4% |
| Q1 2016 | $491,000 | +16.4% | 104,895 | +27.8% | 0.01% | +40.0% |
| Q4 2015 | $422,000 | +57.5% | 82,085 | +15.0% | 0.01% | +25.0% |
| Q3 2015 | $268,000 | -46.8% | 71,406 | -14.9% | 0.01% | -42.9% |
| Q2 2015 | $504,000 | +600.0% | 83,865 | +101.8% | 0.01% | +600.0% |
| Q2 2013 | $72,000 | – | 41,554 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Consonance Capital Management LP | 5,188,417 | $85,349,000 | 7.80% |
| TANAKA CAPITAL MANAGEMENT INC | 144,602 | $2,379,000 | 5.69% |
| INGALLS & SNYDER LLC | 6,817,540 | $112,149,000 | 5.47% |
| NEXTHERA CAPITAL LP | 1,045,196 | $17,193,000 | 2.83% |
| Timpani Capital Management LLC | 245,279 | $4,035,000 | 1.41% |
| S&T BANK/PA | 426,257 | $7,012,000 | 1.25% |
| SHAKER INVESTMENTS LLC/OH | 107,670 | $1,771,000 | 1.10% |
| ESSEX INVESTMENT MANAGEMENT CO LLC | 434,624 | $7,150,000 | 0.94% |
| AMI ASSET MANAGEMENT CORP | 709,300 | $11,668,000 | 0.83% |
| Birchview Capital, LP | 75,500 | $1,242,000 | 0.82% |